About

The Prenatal Information Research Consortium brings together researchers with an interest in ethical, social, and legal aspects of screening and diagnosis in the prenatal, preconception, and perinatal periods. Our research group includes scholars with expertise in bioethics, genetics/genomics, obstetrics/gynecology, sociology, anthropology, public health, rhetoric, science and technology studies, disability studies, and the law. Below find profiles of our affiliated researchers.

For more information, contact us here.

Megan Allyse, PhD

Megan Allyse has researched and publishes extensively on the translation of genetic technologies, with special focus on non-invasive prenatal genomic technologies.

Subhashini Chandrasekharan, PhD

Subhashini Chandrasekharan conducts research on the commercialization of noninvasive prenatal genetic testing technologies and barriers to clinical adoption and patient access in the US and in developing countries.

Melissa Constantine, PhD

Melissa Constantine conducts research on ethical issues in prenatal testing and women’s health, and particularly on issues of informed decision-making.

Ruth Farrell, MD

Ruth Farrell is an obstetrician/gynecologist and bioethicist who has conducted extensive research on clinical and patient perspectives on prenatal screening and testing, particularly prenatal cfDNA screening.

Josephine Johnston, LLB, MBHL

Josephine Johnston’s current projects address the ethical implications of new kinds of prenatal genetic tests, gene editing technologies, and the potential use of genetic sequencing in newborns.

Stephanie Kraft, JD

Stephanie Kraft has conducted survey and interview research on stakeholder experiences and opinions regarding prenatal cfDNA screening.

Mark Leach, JD, MBE

Mark Leach’s research focuses on the state of prenatal testing and its ethical administration.

Michelle L. McGowan, PhD

Michelle McGowan’s research focuses on the ethical and social implications of commercial and clinical applications of reproductive and genomic technologies.

Stephanie Meredith

Stephanie Meredith is the author and co-author of multiple resources for new and expectant parents receiving a diagnosis of Down syndrome and other genetic conditions.

Marsha Michie, PhD

Marsha Michie’s research explores the progress of prenatal cell-free DNA screening and what it can teach us about ethically developing new genetic technologies.

Mollie Minear, PhD

Mollie Minear has conducted research on the use and uptake of prenatal cfDNA screening in the developing world, and on its impact on the disability community.

Jessica Mozersky, PhD

Jessica Mozersky’s research explores the ethical and social implications of new genetic technologies, including prenatal cfDNA screening.

Ainsley Newson, LLB, PhD

Ainsley Newson’s research focuses on ethics, genetics, emerging biotechnologies, and human reproduction, including mitochondrial donation.

Lindsay Parham

Lindsay Parham’s work focuses on the governance systems surrounding new prenatal genetic testing technologies, particularly the creation and meanings of risk.

Rayna Rapp, PhD

Rayna Rapp’s research and writing has long examined the “simultaneously liberating and eugenic aspects” of prenatal testing technologies, particularly amniocentesis.

Vardit Ravitsky, PhD

Vardit Ravitsky’s research addresses ethical and policy issues in reproductive technologies and genetics, most recently the implementation of non-invasive prenatal testing in Canada.

About

Like this: